Trademark Search in Canada

ABTRAYGE

View On IC.GC.CA

REGISTERED

on 25 Oct 2023

Last Applicant/ Owned by

APROGEN INC.

B2F, 545, Dunchon-daero,Jungwon-gu,Seongnam-siGyeonggi-do 13215

Serial Number

2129555 filed on 27^th Jul 2021

Registration Number

TMA1205062 registered on 25^th Oct 2023

Registration expiry Date

27^th Jul 2031

Correspondent Address

MOFFAT & CO.

P.O. Box 2088, Station DOttawa

ONTARIO

K1P5W3

ABTRAYGE

Trademark usage description

pharmaceutical and medicines for human purposes, namely: preparations for the prevention and treatment of oncological diseases; pharmaceutical prepara Read More

Classification Information

Class [005]
Pharmaceutical and medicines for human purposes, namely: preparations for the prevention and treatment of oncological diseases; pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products in the treatment of oncological diseases; pharmaceutical preparations for the treatment and prevention of cancer; pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for the prevention of osteoporosis; pharmaceutical reparations for the central nervous system; pharmaceutical preparations for the treatment of gastro-intestinal diseases; pharmaceutical preparations for immunomodulation; pharmaceutical preparations for immune-enhancing; pharmaceutical preparations for intestinal health and for the prevention and treatment of respiratory diseases; pharmaceutical preparations for the treatment of digestive diseases; pharmaceutical preparations for the treatment of musculoskeletal disorders; pharmaceutical medicines for the treatment of gastrointestinal diseases; medicines for the treatment of mental health disorders; preparations for the treatment of eye diseases and conditions; medicines for the treatment of cardiovascular and cerebrovascular diseases; pharmaceutical preparations for the treatment of gastroenterological, intestine, bowel, stomach and digestive disorders; medicines for the treatment of gastrointestinal diseases; pharmaceutical antibody preparations for the treatment of cancer; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations, namely, antibodies for the treatment of acute respiratory distress syndrome (ARDS); pharmaceutical preparations for the treatment of auto-immune diseases; anti-cancer preparations; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer

Classification kind code

Mark Details

Serial Number

2129555

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 22 on 19^th Dec 2022	Search Recorded
Submitted for opposition 20 on 19^th Dec 2022	Examiner's First Report
Submitted for opposition 223 on 19^th Dec 2022	Total Provisional Refusal
Submitted for opposition 80 on 8^th Dec 2022	Change of Title Registered
Submitted for opposition 256 on 27^th Jun 2022	Notification of Possible Opposition Sent
Submitted for opposition 257 on 26^th Aug 2021	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 25^th Aug 2021	Created
Submitted for opposition 31 on 25^th Aug 2021	Formalized
Submitted for opposition 228 on 27^th Jul 2021	International Registration
Submitted for opposition 30 on 27^th Jul 2021	Filed